DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
« Back to Dashboard
Lorlatinibis the generic ingredient in one branded drug marketed by Pfizer and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Lorlatinib has eighty-one patent family members in forty-seven countries.
One supplier is listed for this compound.
Summary for lorlatinib
|Finished Product Suppliers / Packagers:||1|
|Raw Ingredient (Bulk) Api Vendors:||50|
|What excipients (inactive ingredients) are in lorlatinib?||lorlatinib excipients list|
|DailyMed Link:||lorlatinib at DailyMed|
Recent Clinical Trials for lorlatinib
Identify potential brand extensions & 505(b)(2) entrants
|University of Colorado, Denver||Phase 1|
|National Cancer Institute (NCI)||Phase 1|
|European Organisation for Research and Treatment of Cancer - EORTC||Phase 2|
Pharmacology for lorlatinib
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Pfizer||LORBRENA||lorlatinib||TABLET;ORAL||210868-001||Nov 2, 2018||RX||Yes||No||⤷ Try it Free||⤷ Try it Free||Y||⤷ Try it Free|
|Pfizer||LORBRENA||lorlatinib||TABLET;ORAL||210868-002||Nov 2, 2018||RX||Yes||Yes||⤷ Try it Free||⤷ Try it Free||⤷ Try it Free|
|Pfizer||LORBRENA||lorlatinib||TABLET;ORAL||210868-001||Nov 2, 2018||RX||Yes||No||⤷ Try it Free||⤷ Try it Free||Y||Y||⤷ Try it Free|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Patent Number||Supplementary Protection Certificate||SPC Country||SPC Expiration||SPC Description|
|2822953||122019000088||Germany||⤷ Try it Free||PRODUCT NAME: LORLATINIB ODER PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/19/1355 20190506|
|2822953||PA2019519,C2822953||Lithuania||⤷ Try it Free||PRODUCT NAME: LORLATINIBAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/19/1355 20190506|
|2822953||2019C/539||Belgium||⤷ Try it Free||PRODUCT NAME: LORLATINIB; AUTHORISATION NUMBER AND DATE: EU/1/19/1355 20190508|
|>Patent Number||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration||>SPC Description|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.